{"id":"NCT05175131","sponsor":"Abbott","briefTitle":"Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders","officialTitle":"Multicenter, Randomized, Parallel-group, Open-label, Comparative Clinical Study to Evaluate Efficacy and Safety of Mebeverine+Simethicone Fixed-dose Combination Versus Duspatalin速 (Mebeverine) and Versus Espumisan速 (Simethicone) in Patients With Functional Bowel Disorders With Abdominal Pain and Excess Gas Formation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-11-27","primaryCompletion":"2021-05-18","completion":"2021-05-18","firstPosted":"2022-01-03","resultsPosted":"2024-01-03","lastUpdate":"2024-01-03"},"enrollment":465,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Functional Bowel Disorder"],"interventions":[{"type":"DRUG","name":"Mebeverine+Simethicone","otherNames":[]},{"type":"DRUG","name":"Mebeverine","otherNames":[]},{"type":"DRUG","name":"Simethicone","otherNames":[]}],"arms":[{"label":"Mebeverine+Simethicone combination","type":"EXPERIMENTAL"},{"label":"mebeverine","type":"ACTIVE_COMPARATOR"},{"label":"simethicone","type":"ACTIVE_COMPARATOR"}],"summary":"The parallel three-group study of efficacy and safety was planned to investigate the reduction in abdominal pain and bloating during treatment with the fixed-dose combination of Mebeverine + Simethicone versus Duspatalin速 and Espumisan速 as a monotherapy (Protocol No. MESI3001).","primaryOutcome":{"measure":"Change From Baseline of Sum of NRS-11 Abdominal Pain and Bloating/Flatulence Intensity Scores After 4 Weeks of Treatment.","timeFrame":"4 weeks","effectByArm":[{"arm":"Mebeverine+Simethicone Combination","deltaMin":-7.23,"sd":3.42},{"arm":"Mebeverine","deltaMin":-6.48,"sd":3.48},{"arm":"Simethicone","deltaMin":-5.86,"sd":3.72}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0042"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":155},"commonTop":["Headache","Nausea","Asthenia"]}}